GINETANTUM 10BUST VAG 500MG

GINETANTUM 500 MG CUTAN FOR EXTERNAL GENITIES

active ingredients

Each bag contains: active ingredient: benzidamine hydrochloride 500 mg. Each bottle contains: active ingredient: benzidamine hydrochloride 500 mg. Excipients with known effects: base pink perfume (Benzil alcohol, Benzil benzoato, Benzil cinnamato, Benzil salicilato, Citral, Citronellol, Eugenol, Farnesol, Geraniol, Limonene Linanool) For the full list of excipients, see paragraph 6.1.

Excellent

Granulated for skin solution: trimethylcetylammonium-p-toluensulphonate, sodium chloride, povidone. Concentrated for skin solution: trimethylcetylammonium-p-toluensulphonate, scent of pink base, purified water.

Therapeutic indications

Vulvovaginiti of any origin and nature to prevailing vulvary component, characterized by small vaginal losses, itching, irritation, burning and vulvary pain. Intimate hygiene during the boxer.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1.

Population

Population Use for washing external genitals once or twice a day for up to 7 days. Method of administration Dissolve the contents of 1-2 sachets or 1-2 bottles in 1 liter of water.

Conservation

This medicine does not require any special condition of conservation.

Warnings

Ginetantum should be used locally for the washing of external genitals. You're not ingested. The use of the product, especially if prolonged, could give rise to awareness phenomena. In this case it is necessary to suspend treatment and to take appropriate therapeutic measures. Invite the patient to contact the doctor before use in case of vaginal bleeding and/or leucorrea.

Interactions

Not known

Effects

Occasionally, especially with prolonged use of the product, skin irritations may occur. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions occurring after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

Intoxication is expected only in case of accidental ingestion of high quantities of benzidamine (>300 mg). Symptoms associated with overdose by ingestion of benzidamine are mainly of gastrointestinal nature and dependent on the central nervous system. The most frequent gastrointestinal symptoms are nausea, vomiting, abdominal pain and esophageal irritation. Symptoms to the central nervous system include dizziness, hallucinations, agitation, anxiety and irritability. In case of acute overdose, only symptomatic treatment can be performed. Patients should be kept under close observation, and should receive support treatment. An adequate hydration must be maintained.

There are no contraindications to the topical use of benzidamine during pregnancy or breastfeeding.

Source: Farmadati